Laura Deming

Laura Deming, a visionary technologist and venture capitalist, is on a mission to revolutionize longevity. She discusses the philosophical implications of personal identity in the context of anti-aging and cryopreservation. Deming explores what a ‘humane transhumanism’ could look like and highlights the power of scientific awe in sparking innovation. Insights into mentorship in science showcase its impact on aspiring researchers. Lastly, she dives deep into the potential of reversible cryopreservation as a groundbreaking solution for aging and terminal illnesses.

Laura Deming, the founder of The Longevity Fund and a venture capitalist in anti-aging technology, discusses transformative ideas around human longevity. She explores how we might manipulate aging in humans, not just accept decline as inevitable. Laura highlights a recent breakthrough in lifespan extension for dogs and emphasizes a social approach to the challenge of aging. She advocates for agency over our health choices and envisions a world where extended lifespans allow us to remain active and engaged well into our later years.

with @LauraDeming, @kpfortney, @vijaypande, and @omnivorousread Welcome to the first episode of Bio Eats World, a brand new podcast all about how biology is technology. Bio is breaking out of the lab and clinic and into our daily lives—on the verge of revolutionizing our world in ways we are only just beginning to imagine. In this episode, we talk all about the science of aging. Once a fringe field, aging research is now entering a new phase with the first clinical trials of aging-related drugs. As the entire field shifts into this moment of translation, what have we learned? What are the basic approaches to developing aging-related drugs? How is studying aging helping us understand diseases like cancer and Alzheimer's—and increasing the amount of time we are healthy—today?  In this conversation, Laura Deming, founder of The Longevity Fund; Kristen Fortney, co-founder of BioAge, a clinical-stage company focused on finding drugs to extend healthspan; Vijay Pande, general partner at a16z; and host Hanne Winarsky discuss the entire arc of aging science from one genetic tweak in a tiny worm to changing a whole paradigm of healthcare delivery.

(01:21) - Inside ChatGPT’s Everyday Uses (35:28) - 𝕏 Timeline Reactions (58:21) - John Shahidi is an Iranian-American entrepreneur and content/media executive based in Newport Beach, California. He co-founded Shots Studios (formerly Rock Software / RockLive) with his brother Sam Shahidi, originally doing mobile games and celebrity apps before shifting into talent management, content production, and podcasting. He also serves as President of Happy Dad Hard Seltzer & Tea and leads the Shots Podcast Network. He’s known for his ability to pivot from apps to multimedia ventures, working with influencers and creative talent, blending media, marketing, and branding in youth-oriented digital culture. (01:45:43) - 𝕏 Timeline Reactions (02:00:30) - Laura Deming, a venture capitalist and founder of the Longevity Fund, discusses her work at Until Labs, where she aims to develop hibernation pods akin to those in science fiction, with the immediate goal of cryopreserving human organs to improve transplant logistics. She highlights the challenges of scaling cryopreservation from embryos to human organs, emphasizing the need to prevent ice formation during the freezing process. Deming also touches on the potential future applications of this technology, including long-term space travel and extending human lifespan by pausing biological processes. (02:27:05) - 𝕏 Timeline Reactions (02:31:17) - Kimbal Musk, an entrepreneur and philanthropist, co-founded The Kitchen Restaurant Group and the nonprofit Big Green, focusing on sustainable food systems and education. In the conversation, he discusses the success of Nova Sky Stories' Vatican show, which attracted 300,000 attendees, and highlights plans for future large-scale drone art performances worldwide. He also emphasizes the importance of expanding their drone fleet to meet growing demand and maintaining a 100% safety record. (02:49:01) - Steven Glinert, CEO of Sphere Semi, announced the company's successful $12 million funding round led by Acme Capital and Future Ventures, bringing their total funding to $20 million. He emphasized Sphere Semi's focus on revolutionizing analog semiconductor design through AI, aiming to automate the traditionally manual process and enhance efficiency. Glinert also highlighted the company's strategic expansion into the defense sector, particularly in developing RF components, and plans to venture into mixed-signal chips to meet the growing demands of data centers. (02:57:29) - Ethan Barajas, co-founder and CEO of Icarus Robotics, is leading the development of dexterous, free-flying robots designed to perform routine maintenance and logistics tasks aboard spacecraft, thereby allowing astronauts to focus on scientific research and manufacturing. These robots, which can be controlled from the ground, aim to reduce the high costs associated with astronaut labor, estimated at $135,000 per hour. Icarus Robotics has secured a $6.1 million seed funding round and plans to launch their robots to the International Space Station by late 2026 or early 2027 for a year-long testing phase. (03:06:10) - Austin Petersmith, co-founder and CEO of Howie.ai, discusses the company's recent $6 million seed funding and the launch of their AI-powered scheduling assistant, Howie, which combines advanced models with human oversight to optimize meeting arrangements. He explains the product's pricing tiers—$35 per month for the base version and $145 for the Pro version, which offers white-labeling and advanced preferences—and addresses the challenges of balancing AI automation with human verification to ensure accuracy. Petersmith also shares insights into the competitive landscape, emphasizing the complexities of developing such a product and expressing confidence in Howie.ai's ability to stay ahead by continually enhancing their offerings. TBPN.com is made possible by: Ramp - https://ramp.comFigma - https://figma.comVanta - https://vanta.comLinear - https://linear.appEight Sleep - https://eightsleep.com/tbpnWander - https://wander.com/tbpnPublic - https://public.comAdQuick - https://adquick.comBezel - https://getbezel.com Numeral - https://www.numeralhq.comPolymarket - https://polymarket.comAttio - https://attio.com/tbpnFin - https://fin.ai/tbpnGraphite - https://graphite.devRestream - https://restream.ioProfound - https://tryprofound.comJulius AI - https://julius.aiturbopuffer - https://turbopuffer.comfal - https://fal.aiPrivy - https://www.privy.ioCognition - https://cognition.aiFollow TBPN: https://TBPN.comhttps://x.com/tbpnhttps://open.spotify.com/show/2L6WMqY3GUPCGBD0dX6p00?si=674252d53acf4231https://podcasts.apple.com/us/podcast/technology-brothers/id1772360235https://www.youtube.com/@TBPNLive

In this podcast, Laura Deming discusses challenging conventional beliefs on aging and healthspan, exploring implications of longer lives and agency over lifespan. The conversation delves into advancing medical research, strategies to extend lifespan in mice, and the potential impact on human health. A fascinating look at the science that could keep us healthy in our 80s and beyond.